BioID Genomics

BioID Genomics (BIG) is a private, early-revenue-stage biotech firm offering an integrated hardware-software platform for microbial identification. Its core technology, the RIDI™ 16S Microbial ID Kit, bypasses complex library preparation, enabling rapid, sample-agnostic detection and characterization of prokaryotes in under 3 hours of hands-on time, followed by cloud-based analysis. The company targets research laboratories seeking accessible, comprehensive microbiome analysis, leveraging over seven years of validated commercial lab use for its underlying technology. With a focus on making sophisticated sequencing more affordable and user-friendly, BIG aims to establish its kit as the 'Platinum Standard' in microbiology research.

Proprietary targeted sequencing (16S rRNA) combined with a cloud-based bioinformatics platform (RIDI™). The wet-lab component uses a unique PCR-based indexing and amplification strategy to replace traditional NGS library prep, enabling rapid, sample-agnostic microbial identification.

BioID competes in the microbial sequencing research tools market against giants like Illumina (instrument and workflow provider) and QIAGEN (sample prep kits), as well as other specialized kit vendors and core sequencing service facilities. Its differentiation is the deeply integrated and simplified workflow from sample to report, targeting labs with limited NGS expertise.